Sarai Alvarez
Medical · Chicago, ILNPI 1114627601
Payments from drug & device makers
Across 109 payments — averaging $34.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$664
- AbbVie$645
- AstraZeneca$492
- Lilly USA, LLC$451
- Johnson & Johnson$283
- Abbott$204
- plus $1K from 13 others
What the payments were for
- Food & beverage$3,67798%
- Education$652%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 22 | $664 |
| AbbVie | 16 | $645 |
| AstraZeneca | 13 | $492 |
| Lilly USA, LLC | 11 | $451 |
| Johnson & Johnson | 3 | $283 |
| Abbott | 5 | $204 |
| Mylan Specialty L.p. | 7 | $179 |
| Bayer | 6 | $155 |
| GSK | 5 | $148 |
| Phathom Pharmaceuticals, Inc. | 2 | $142 |
| Exact Sciences | 5 | $113 |
| Merck | 4 | $63 |
| Pfizer | 3 | $60 |
| Viatris Specialty LLC | 2 | $44 |
| Astellas Pharma US Inc | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Exeltis, USA Inc. | 1 | $19 |
| Cranial Technologies, Inc | 1 | $18 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,742 in reported general payments places this provider in the 85th percentile of 449 medical providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 33 | $36,881 |
| FarxigaDapagliflozin Propanediol | 32 | $25,422 |
| JardianceEmpagliflozin | 18 | $17,254 |
| LinzessLinaclotide | 15 | $12,743 |
| Trueplus Pen NeedlePen Needle, Diabetic | 14 | $814 |
| Valsartan | 41 | $796 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 25 | $598 |
| Nifedipine ErNifedipine | 32 | $504 |
| Atorvastatin Calcium | 69 | $366 |
| Rosuvastatin Calcium | 25 | $312 |
| Pregabalin | 15 | $221 |
| Diclofenac Sodium | 13 | $217 |
| Fluticasone Propionate | 17 | $182 |
| Tamsulosin Hcl | 15 | $168 |
| Metformin Hcl | 38 | $163 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $451 | $36,88133 claims |
| AstraZenecaFarxiga | $492 | $25,42232 claims |
| AbbVieLinzess | $645 | $12,74315 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 449 medical providers in Illinois.
Other medical in Chicago
- Andrea TurekChicago$145K
- Jennifer GarsonChicago$32K
- William KvasnickaChicago$19K
- Brittany WolfeChicago$12K
- Eric KingChicago$9K
- Neema ManappuramChicago$8K
- Robert RadtkeChicago$7K
- Koree RamseyChicago$5K
- Justin OkrayChicago$5K
- Alexis DavidmanChicago$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.